Mesenchymal Stromal Cells in Acute Respiratory Distress Syndrome: Shoulder Heavy Responsibilities, and a Long Way to Go.
作者信息
Zhu Feng
机构信息
Department of Critical Care Medicine, Shanghai East Hospital, Tongji University School of Medicine, Pudong New Area, Shanghai, China.
出版信息
Am J Respir Crit Care Med. 2024 May 15;209(10):1276. doi: 10.1164/rccm.202312-2296LE.
Abstract
摘要
相似文献
1
Mesenchymal Stromal Cells in Acute Respiratory Distress Syndrome: Shoulder Heavy Responsibilities, and a Long Way to Go.
Am J Respir Crit Care Med. 2024 May 15;209(10):1276. doi: 10.1164/rccm.202312-2296LE.
2
Reply to Zhu: Mesenchymal Stromal Cells in Acute Respiratory Distress Syndrome: Shoulder Heavy Responsibilities, and a Long Way to Go.
Am J Respir Crit Care Med. 2024 May 15;209(10):1276-1278. doi: 10.1164/rccm.202312-2364LE.
3
Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome.
Stem Cells Transl Med. 2020 Jan;9(1):28-38. doi: 10.1002/sctm.19-0205. Epub 2019 Oct 24.
4
[Mesenchymal stem cells: a new perspective of treatment of the acute respiratory distress syndrome].
Ann Fr Anesth Reanim. 2014 Jan;33(1):52-3. doi: 10.1016/j.annfar.2013.11.024. Epub 2013 Dec 27.
5
Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
Expert Rev Respir Med. 2021 Mar;15(3):301-324. doi: 10.1080/17476348.2021.1848555. Epub 2020 Nov 26.
6
Understanding the impact of the lung microenvironment to enhance the therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome.
Eur Respir J. 2021 Oct 14;58(4). doi: 10.1183/13993003.00986-2021. Print 2021 Oct.
7
Human Umbilical Cord-Derived Mesenchymal Stem Cells for Acute Respiratory Distress Syndrome.
Crit Care Med. 2020 May;48(5):e391-e399. doi: 10.1097/CCM.0000000000004285.
8
[Research advances on mesenchymal stem cell-mediated mitochondrial transfer for improving lung injury and repair in acute respiratory distress syndrome].
Zhonghua Nei Ke Za Zhi. 2024 May 1;63(5):503-506. doi: 10.3760/cma.j.cn112138-20231024-00242.
9
Mesenchymal stem cells: current clinical progress in ARDS and COVID-19.
Stem Cell Res Ther. 2020 Jul 22;11(1):305. doi: 10.1186/s13287-020-01804-6.
10
Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome.
Stem Cell Res Ther. 2019 Dec 16;10(1):386. doi: 10.1186/s13287-019-1518-0.
本文引用的文献
1
Mesenchymal Stromal Cells in Acute Respiratory Distress Syndrome: More Questions Than Answers.
Am J Respir Crit Care Med. 2023 Dec 15;208(12):1257-1259. doi: 10.1164/rccm.202310-1847ED.
2
Intravenous Autologous Bone Marrow-derived Mesenchymal Stromal Cells Delay Acute Respiratory Distress Syndrome in Swine.
Am J Respir Crit Care Med. 2023 Dec 15;208(12):1283-1292. doi: 10.1164/rccm.202305-0865OC.
3
Prevention of LPS-induced acute respiratory distress syndrome in sheep by bone marrow-derived mesenchymal stem/stromal cells.
Life Sci. 2020 Dec 15;263:118600. doi: 10.1016/j.lfs.2020.118600. Epub 2020 Oct 14.
4
Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial.
Lancet Respir Med. 2019 Feb;7(2):154-162. doi: 10.1016/S2213-2600(18)30418-1. Epub 2018 Nov 16.
Zotero 插件